Bw. Day et al., ENANTIOSPECIFICITY OF COVALENT ADDUCT FORMATION BY BENZO[A]PYRENE ANTI-DIOL EPOXIDE WITH HUMAN SERUM-ALBUMIN, Chemical research in toxicology, 7(6), 1994, pp. 829-835
Human serum albumin was reacted with the (+)- and (-)-enantiomers of y
-t-9,t-10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene to determine if the
chiral nature of the protein influences adduct formation. The alkylate
d proteins were analyzed directly by fluorescence line narrowing spect
roscopy, and their spectra were compared to those of the model synthet
ic adducts 8,t-9,c-10-tetrahydrobenzo[a]pyren-10-yl)histidine and oxy-
r-7,t-8,t-9,c-10-tetrahydrobenzo[a]pyren-10-yl N-t-BOC-alaninate ester
. The results from these analyses indicated that different adducts wer
e formed by the enantiomers of the diol epoxide. The adducted proteins
were also enzymatically digested, and the droxy-7,8,9,10-tetrahydrobe
nzo[a]pyrene-containing adducts and hydrolysis products were isolated
by boronate affinity chromatography. Diode array UV, fast atom bombard
ment, and on-line atmospheric pressure ionization-mass spectral analys
is of the HPLC purified products indicated that the more mutagenic and
tumorigenic (+)-enantiomer forms carboxylic ester adducts with the pr
otein at either Asp(187) or Glu(188), while the (-)-enantiomer forms N
-tau-histidine adducts at His(146). This previously unrealized enantio
specificity of the reaction of benzo[a]pyrene anti-diol epoxide with h
uman serum albumin has important consequences for the application of t
he adducts as biomarkers of internal exposure.